tiprankstipranks
Keymed Biosciences, Inc. (HK:2162)
:2162
Hong Kong Market
2162
Keymed Biosciences, Inc.
RESEARCH TOOLSreports

Keymed Biosciences, Inc. (2162) Stock News & Sentiment

1 Followers
Keymed Biosciences boosts revenue on Kangyueda push while deepening R&D pipeline
Premium
Company Announcements
Keymed Biosciences boosts revenue on Kangyueda push while deepening R&D pipeline
18d ago
2162
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
Premium
Market News
M&A News: Gilead Bets $2B+ on Ouro Medicines to Power Immunology Growth
20d ago
GSK
GILD
Keymed Biosciences to Realize Up to US$320 Million From Ouro Medicines Exit
Premium
Company Announcements
Keymed Biosciences to Realize Up to US$320 Million From Ouro Medicines Exit
20d ago
2162
Keymed Biosciences Sets March 26 Board Meeting to Approve 2025 Results and Consider Final Dividend
Premium
Company Announcements
Keymed Biosciences Sets March 26 Board Meeting to Approve 2025 Results and Consider Final Dividend
28d ago
2162
Keymed Gains US$45 Million Milestone as AstraZeneca Starts Phase III Trial of Core Cancer Drug
Premium
Company Announcements
Keymed Gains US$45 Million Milestone as AstraZeneca Starts Phase III Trial of Core Cancer Drug
1M ago
2162
Keymed Biosciences’ Strategic Positioning and Stapokibart’s Market Potential in Biotech Sector
Premium
Ratings
Keymed Biosciences’ Strategic Positioning and Stapokibart’s Market Potential in Biotech Sector
5M ago
Keymed Biosciences Reports Strong Revenue Growth Amid Leadership Change
Premium
Company Announcements
Keymed Biosciences Reports Strong Revenue Growth Amid Leadership Change
8M ago
2162
More HK:2162 News >

2162 News on the Web

KeyBanc Sticks to Their Buy Rating for Keymed Biosciences, Inc. (2162)
TipRanks News
Neutral
Huatai Securities Remains a Buy on Keymed Biosciences, Inc. (2162)
TipRanks News
Bullish
Huatai Securities Keeps Their Buy Rating on Keymed Biosciences, Inc. (2162)
TipRanks News
Bullish
Keymed Biosciences, Inc. (2162) Receives a Buy from CLSA
TipRanks News
Bullish
Keymed Biosciences boosts revenue on Kangyueda push while deepening R&D pipeline
TipRanks News
Bullish
Keymed Biosciences to Realize Up to US$320 Million From Ouro Medicines Exit
TipRanks News
Bullish
Keymed Biosciences Sets March 26 Board Meeting to Approve 2025 Results and Consider Final Dividend
TipRanks News
Neutral
Keymed Gains US$45 Million Milestone as AstraZeneca Starts Phase III Trial of Core Cancer Drug
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:2162’s Media Buzz Sentiment?
Currently, no data Available
What is HK:2162’s weekly average amount of articles?
Currently, no data Available
What is HK:2162’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week